Bank of America’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bank of America’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,200	Closed	-$88K	–	7687
2014 Q4	$88K	Sell	5,200 -5,400	-51%	-$78.6K	﹤0.01%	5978
2014 Q3	$142K	Buy	10,600 +9,000	+563%	+$107K	﹤0.01%	5724
2014 Q2	$20K	Sell	1,600 -4,400	-73%	-$45.8K	﹤0.01%	7167
2014 Q1	$71K	Sell	6,000 -9,900	-62%	-$133K	﹤0.01%	6224
2013 Q4	$220K	Buy	15,900 +2,300	+17%	+$32.5K	﹤0.01%	5506
2013 Q3	$237K	Sell	13,600 -400	-3%	-$7.66K	﹤0.01%	5308
2013 Q2	$227K	Buy	+14,000	New	+$433K	﹤0.01%	5504

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Bank of America's INFI Position: Q3 2023 in Review

Bank of America sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 758 shares — an estimated $159 sold.

Bank of America first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $968K in Q2 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Bank of America reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Bank of America sold 758 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $159.
Bank of America first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
Bank of America's Infinity Pharmaceuticals, Inc. position peaked at $968K in Q2 2013.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.